Tumour immunology: the end of the beginning.
作者信息
Hall J G
出版信息
Practitioner. 1982 Dec;226(1374):2010-20.
PMID:7170295
Abstract
摘要
相似文献
1
Tumour immunology: the end of the beginning.肿瘤免疫学：开端的结束。
Practitioner. 1982 Dec;226(1374):2010-20.
2
An introduction to tumour immunology.肿瘤免疫学导论
Arch Immunol Ther Exp (Warsz). 1983;31(6):795-808.
3
Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.人类肿瘤相关抗原：单克隆抗体介导的癌症治疗靶点
Cancer Surv. 1985;4(1):271-90.
4
[Immunology: new approaches to immuno-modulation and immunotherapy].[免疫学：免疫调节与免疫治疗的新方法]
Dtsch Med Wochenschr. 2006 Jun 23;131(25-26):1471-3. doi: 10.1055/s-2006-946604.
5
[Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].[蛋白酶体对肽的剪接发现及抗癌免疫治疗临床前模型研究]
Bull Mem Acad R Med Belg. 2007;162(5-6):352-6.
6
Third international Dresden symposium on immunotherapy of cancer.第三届德累斯顿国际癌症免疫治疗研讨会
Cancer Res. 2001 Apr 15;61(8):3524-8.
7
Possibilities for active immunotherapy of human cancer.
Cancer Invest. 1992;10(4):285-93. doi: 10.3109/07357909209032753.
8
Tumour immunotherapy: the adjuvant treatment of the 21st century?肿瘤免疫疗法：21世纪的辅助治疗手段？
Eur J Surg Oncol. 2000 Jun;26(4):418-24. doi: 10.1053/ejso.1999.0908.
9
Cancer immunotherapy: a treatment for the masses.癌症免疫疗法：一种面向大众的治疗方法。
Science. 2004 Jul 9;305(5681):200-5. doi: 10.1126/science.1100369.
10
Anti-idiotypic tumor vaccines.抗独特型肿瘤疫苗。
Int Rev Immunol. 1989;4(4):337-46. doi: 10.3109/08830188909044786.
Zotero 插件